share_log
Reuters ·  Jan 29 21:01
European Commission Approves Blincyto® in Philadelphia Chromosome-Negative Cd19-Positive B-Cell Precursor Acute Lymphoblastic Leukemia in the Consolidation Phase
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 209

Recommended

Write a comment